文献速递新发突发、热带与寄生虫病

大湄公河次区域青蒿素耐药恶性疟原虫的分子流行病学传播研究

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.
PubMed 文献 · Lancet Infect Dis · 2017-02-02

该观察性研究对2008至2015年缅甸、泰国东北部、老挝南部和柬埔寨西部采集的434株恶性疟原虫分离株进行PfKelch13突变和Pfplasmepsin2基因扩增检测,并用微卫星基因分型评估遗传相关性。结果显示,2008年起源于柬埔寨西部的单一长PfKelch13 C580Y单倍型谱系在2014-15年扩散至泰国东北部和老挝南部,形成跨国选择性清除,且在该谱系内出现哌喹耐药。缅甸的C580Y突变虫株具有不同遗传起源。

要点

  • 柬埔寨西部起源的C580Y谱系扩散至泰国和老挝并竞争取代其他虫株。
  • 哌喹耐药仅出现在该C580Y谱系内,提示伴侣药物耐药获得。
  • 缅甸C580Y虫株遗传起源不同,未参与同一扩散事件。

核心结论

  • 优势青蒿素耐药C580Y谱系可能起源于柬埔寨西部并传播至泰国和老挝,竞争取代其他虫株并获得哌喹耐药。

研究设计与样本

  • 检测PfKelch13突变和Pfplasmepsin2基因扩增,并用微卫星基因分型评估遗传相关性。

主要发现

  • 2014-15年,2008年起源于柬埔寨西部的单一长PfKelch13 C580Y单倍型谱系在泰国东北部88株中检出65株、老挝南部111株中检出86株、柬埔寨西部14株中全部检出,提示跨国选择性清除。
  • 缅甸的C580Y突变寄生虫具有不同遗传起源。

临床怎么用

  • 应加速消除该区域恶性疟,趁现有抗疟药仍有效时控制耐药谱系传播。
  • 需监测C580Y谱系及其获得的哌喹耐药,以指导区域疟疾控制与消除策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence suggests that the PfKelch13 mutations that confer artemisinin resistance in falciparum malaria have multiple independent origins across the Greater Mekong subregion, which has motivated a regional malaria elimination agenda. We aimed to use molecular genotyping to assess antimalarial drug resistance selection and spread in the Greater Mekong subregion. METHODS: In this observational study, we tested Plasmodium falciparum isolates from Myanmar, northeastern Thailand, southern Laos, and western Cambodia for PfKelch13 mutations and for Pfplasmepsin2 gene amplification (indicating piperaquine resistance). We collected blood spots from patients with microscopy or rapid test confirmed uncomplicated falciparum malaria. We used microsatellite genotyping to assess genetic relatedness. FINDINGS: As part of studies on the epidemiology of artemisinin-resistant malaria between Jan 1, 2008, and Dec 31, 2015, we collected 434 isolates. In 2014-15, a single long PfKelch13 C580Y haplotype (-50 to +31·5 kb) lineage, which emerged in western Cambodia in 2008, was detected in 65 of 88 isolates from northeastern Thailand, 86 of 111 isolates from southern Laos, and 14 of 14 isolates from western Cambodia, signifying a hard transnational selective sweep. Pfplasmepsin2 amplification occurred only within this lineage, and by 2015 these closely related parasites were found in ten of the 14 isolates from Cambodia and 15 of 15 isolates from northeastern Thailand. C580Y mutated parasites from Myanmar had a different genetic origin. INTERPRETATION: Our results suggest that the dominant artemisinin-resistant P falciparum C580Y lineage probably arose in western Cambodia and then spread to Thailand and Laos, outcompeting other parasites and acquiring piperaquine resistance. The emergence and spread of fit artemisinin-resistant P falciparum parasite lineages, which then acquire partner drug resistance across the Greater Mekong subregion, threatens regional malaria control and elimination goals. Elimination of falciparum malaria from this region should be accelerated while available antimalarial drugs still remain effective. FUNDING: The Wellcome Trust and the Bill and Melinda Gates Foundation.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Imwong M, Suwannasin K, Kunasol C, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017. PMID: 28161569. doi:10.1016/S1473-3099(17)30048-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。